Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2006

01-05-2006 | Letter to the Editor

Caution Needed in Fluoride and Osteosarcoma Study

Authors: Chester W. Douglass, Kaumudi Joshipura

Published in: Cancer Causes & Control | Issue 4/2006

Login to get access

Excerpt

This issue of Cancer Causes and Controls includes a paper with results from an analysis of a subset of participants in our ongoing study of fluoride and osteosarcoma. The paper, “Age-specific fluoride exposure in drinking water and osteosarcoma”, presents a partial view of this ongoing study. We would like to advise the readers to be especially cautious when interpreting the findings of this paper for several reasons. The authors themselves have already raised a flag of caution in their final paragraph with the note that they are aware of additional findings from other incident cases that appear not to replicate the findings from the cases presented in their paper. …
Literature
1.
The National Toxicology Program (NTP). Supplemental 2-year study of sodium fluoride in male F344 rats (CAS No. 7681–49–4)
2.
National Toxicology Program (1990) Toxicology and carcinogenesis of sodium fluoride in F344 TN rats and B 6C3FL mice. Technical Report Services 393, NIH Publication No. 90–2848
Metadata
Title
Caution Needed in Fluoride and Osteosarcoma Study
Authors
Chester W. Douglass
Kaumudi Joshipura
Publication date
01-05-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0008-8

Other articles of this Issue 4/2006

Cancer Causes & Control 4/2006 Go to the issue

Special Section on Cancer and Rhythm

Risk of Breast Cancer After Night- and Shift Work: Current Evidence and Ongoing Studies in Denmark

Review Article

Of Mice and Women: Light as a Circadian Stimulus in Breast Cancer Research

Special Section on Cancer and Rhythm

Biological Clocks and Shift Work: Circadian Dysregulation and Potential Long-term Effects

Original Paper

Incidences and Trends of Second Cancers in Female Breast Cancer Patients: A Fixed Inception Cohort-based Analysis (United States)

Special Section on Cancer and Rhythm

Is Melatonin the Hormonal Missing Link Between Magnetic Field Effects and Human Diseases?

Special Section on Cancer and Rhythm

Circulating Melatonin Levels: Possible Link Between Parkinson’s Disease and Cancer Risk?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits